Recall Z-1647-2026

Philips Respironics, Inc. · initiated March 2, 2026

Class I Open, Classified

Class I – dangerous or defective products that could cause serious health problems or death

Product

Philips Respironics Trilogy Evo O2, Software Version 1.05.15.00. Continuous home-use ventilator device.

Codes / lots: All Model No.; All UDI; All Serial No.

Reason for recall

In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.

FDA-determined cause: Software design

Action taken

An IMPORTANT PRODUCT NOTICE was mailed to consignees 6/5/24 about obstruction alarm compliance failure in Trilogy Evo devices. Refer to the most current version of the IFU in the event of an obstruction. A software update to correct this issue is pending. An UPDATED: URGENT FIELD SAFETY NOTICE was mailed 3/2/26 with recall information for three failure modes possible in all Trilogy Evo, Trilogy EVO O2, Trilogy Evo Universal, and Trilogy EV300. Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient. This can lead to under-delivery of therapy to the patient. Update all devices with software version 1.05.15.00 through the My Philips for Professionals and InCenter websites. Stop use of non-pneumatic nebulizers, including vibrating mesh nebulizers, with all affected devices. Distributors give your customers the provided recall notice and response form. DME and Homecare Customers call 1-800-345-6443 (option 2, option 1) for assistance. Hospital Customers call 1-800-722-9377 (option 2) for assistance. **An UPDATED: URGENT FIELD SAFETY NOTICE was mailed to consignees 4/24/26 with recall information for three failure modes possible in all Trilogy Evo, Trilogy EVO O2, Trilogy Evo Universal, and Trilogy EV300 devices. It clarifies and revises guidance about the use of non-pneumatic nebulizers with Trilogy Evo Platform ventilators communicated in the 3/2/26 update. This does not change this previously communicated information: Nebulized aerosol deposition on the internal flow sensor (FSN 2024-CC-SRC-013 - Flow Sensor Nebulized Aerosol Deposition), and Obstruction Alarm timing (IPN 2024-CC-SRC-002 - Obstruction Alarm). Consignees review the latest version of the User Manual Addendum, give the safety notice to all who interact with affected devices, and forward the notice to those to whom product was further distributed.

Details

Recall number
Z-1647-2026
Initiated
March 2, 2026
Posted by FDA
April 2, 2026
Product code
CBK – Ventilator, Continuous, Facility Use
Quantity
113,717 units
Distribution
Worldwide Distribution. US Nationwide, Argentina, Austria, Australia, Bosnia and Herzegovina, Bangladesh, Belgium, Bulgaria, Bolivia, Brazil, Bahamas, Canada, Switzerland, Chile, China, Colombia, Czech Republic, Germany, Denmark, Algeria, Ecuador, Estonia, Egypt, Spain, Finland, France, Georgia, French Guiana, Gibraltar, Greece, Guatemala, Hong Kong, Croatia, Hungary, Indonesia, Ireland, Israel…
Recalling firm
Philips Respironics, Inc., Murrysville, PA

Official FDA recall record

Other products in the same recall event

RecallProductInitiated
Z-1646-2026 Class IPhilips Respironics Trilogy Evo, Software Version 1.05.15.00. Continuous home-use…In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant… 03/02/2026Open, Classified
Z-1648-2026 Class IPhilips Respironics Trilogy EV300, Software Version 1.05.15.00. Continuous home-use…In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant… 03/02/2026Open, Classified
Z-1649-2026 Class IPhilips Respironics Trilogy Evo Universal, Software Version 1.05.15.00. Continuous…In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant… 03/02/2026Open, Classified